News|Articles|November 24, 2025
Rethinking Clinical Trial Data in the Era of Decentralization
Author(s)Seriant
Related Content
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
What Pharma Investors Should Expect in the Current Regulatory Environment
5